Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.



Li-Xi Yang, M.D., Ph.D.

California Pacific Medical Center Research Institute # of Grants: 2

Grants

Improved therapy of lung cancer 2000 (Cycle 9) $668,814
Cancer Research Project Awards

Improved chemoradiotherapy of lung cancer 2005 (Cycle 14) $659,033
Cancer Research Project Awards
Publications

Centrosomes-their role in tumors and cancer therapy.
Periodical: Anticancer Research Index Medicus:
Authors: Ro S, Yang LX ART
Yr: 2004 Vol: 24 Nbr: Abs: Pg:

A Novel Camptotheicin Analog with Enhanced Anitiumor Activity
Periodical: Anticancer Research Index Medicus:
Authors: Yount G, Yang Y, Wong B, Wang HJ, and Yang LX ART
Yr: 2007 Vol: Nbr: Abs: Pg:

Novel camptothecin derivatives.
Periodical: In Vivo Index Medicus:
Authors: Legarza, K, Yang LX ART
Yr: 2005 Vol: 19 Nbr: Abs: Pg: 283-292

New molecular mechanisms of action of camptothecin-type drugs.
Periodical: Anticancer Research Index Medicus:
Authors: Legarza k. Yang LX ART
Yr: 2006 Vol: 26 Nbr: 5 Abs: Pg: 3301-3306

Design, synthesis and development of novel camptothecin drugs.
Periodical: Current Pharmaceutical Design Index Medicus:
Authors: Lieu T, Yang LX ART
Yr: 2008 Vol: 14 Nbr: 11 Abs: Pg: 1078-1097

gamma-H2AX - A novel biomarker for DNA double-strand breaks.
Periodical: In Vivo Index Medicus:
Authors: Kuo L, Yang LX ART
Yr: 2008 Vol: 22 Nbr: 3 Abs: Pg: 305-310

Enhancement of radiation-induced DNA damage and inhibition of its repair by a novel camptothecin analog.
Periodical: Anticancer Research Index Medicus:
Authors: Huang G, Wang HJ, Yang LX ART
Yr: 2009 Vol: Nbr: Abs: Pg: